Category list : Antiviral agents
Sort by: Newest first Oldest first A-Z Z-A
-
Existing drugs are effective against human parainfluenza virus Subscription
Study shows that suramin combined with zanamivir acts synergistically to inhibit human parainfluenza type-3 virus infection.
-
NHS England pulling the plug on PrEP for HIV prevention is unacceptable Subscription
I wish to draw your attention to NHS England’s sudden abandonment of its own processes in a shocking U-turn on access to HIV game changer pre-exposure prophylaxis (PrEP; emtricitabine/tenofovir, marketed as Truvada).
-
High-risk women need more frequent doses of HIV drugs Subscription
Researchers say more frequent pre-exposure prophylaxis is required to protect women from HIV.
-
Exposure to atazanavir in womb linked to neurodevelopmental problems in infants Subscription
Babies exposed to the HIV drug atazanavir in the womb may have impaired language and social-emotional development at one year, suggests a new study.
-
HIV resistance to tenofovir surprisingly common Subscription
International study finds high proportion of HIV patients were resistant to cART drug tenofovir.
-
Daklinza licence extension Subscription
Daklinza (daclatasvir; Bristol Myers Squibb), used in combination with other drugs to treat hepatitis C, has been approved for extended use for patients co-infected with HIV and also post liver transplantation by the European Medicines Agency.
-
Antivirals in immunocompromised patients Subscription
Public Health England (PHE) has issued updated guidance on prophylaxis of influenza in severely immunocompromised patients. It now recommends that zanamavir is used as the first line antiviral instead of oseltamivir. The guidance can be accessed via the
-
Researchers unravel function of HIV defence protein Subscription
Researchers investigate why TRIM5α protein lost ability to degrade HIV in rhesus monkey study.
-
Targeting hepatitis C — how new treatments work Subscription
There are >185 million people with hepatitis C infection worldwide but new treatments mean that most people with access to therapy can now be cured.
-
Harvoni for hepatitis C genotypes 5 and 6 Subscription
The summary of product characteristics for Harvoni (ledipasvir and sofosbuvir; Gilead), used to treat hepatitis C, has been updated to include information about posology and the method of administration for patients with genotype 5 or 6 — it previously only included genotypes 1 and 4.
Show 10 per page20 per page50 per page
